Impact of Proposed Cuts to NIH Budget:

More Than Just About Cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

If enacted, the proposed budget reduction of $5.8 billion to the National Institutes of Health will slow research, deprive patients afflicted with cancer of hope, and deliver a devastating blow to our science workforce and the Commonwealth of Pennsylvania. This proposed reduction directly counters the wisdom of the U.S. Congress, who less than a year ago overwhelmingly passed the 21st Century Cures Act.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
Karen E. Knudsen, PhD
Director, Sidney Kimmel Cancer Center, Thomas Jefferson University
Chi Van Dang, MD, PhD
Director, Abramson Cancer Center, University of Pennsylvania
Richard I. Fisher, MD
Director, Fox Chase Cancer Center, Temple University Health System
Edward Chu, MD
Interim director, University of Pittsburgh Cancer Institute
Dario Altieri, MD
Director, Wistar Institute Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login